AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01155518 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: intramuscular saline injections every 2 weeks
Study NCT01155518 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: oral
Study NCT02522663 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 24/7-telephone support
Description: ICU nurses answer the calls from treated AVR patients during the first month after discharge, and use an evidence-based information manual to answer questions from the patients.
Study NCT02966444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MUFA-rich HF Meal
Study NCT02966444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PUFA-rich HF Meal
Study NCT02966444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SFA-rich HF Meal
Study NCT01391052 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norethindrone acetate pretreatment
Description: 5 mg tablets, three times a day for 21 days for 2 menstrual cycles.
Study NCT01391052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No pretreatment
Description: LVN IUS is placed withour Norethindrone acetate pretreatment.
Study NCT04208971 — intervention group
Intervention type: OTHER
Intervention: AI-enabled ECG-based Screening Tool for AF
Description: A novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool to improve atrial fibrillation diagnosis and stroke prevention.
Study NCT02050893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sedatives(Midazolam and Propofol)
Study NCT02153619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meaning-Centered Grief Therapy (MCGT)
Description: MCGT is a manualized, one-on-one intervention that uses psychoeducation, experiential exercises, and homework focusing on themes related to meaning, identity, purpose, and legacy. Post-intervention qualitative exit interviews will assess acceptability of the MCGT intervention (see Appendix I). Participants randomized to MCGT will provide their feedback about MCGT and the measures (n = 33).
Study NCT02153619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Psychotherapy (SP)
Description: SP is the comparison condition in this study and is a standardized, manualized intervention developed by the MSK Psychiatry Service and utilized in our completed and ongoing RCTs of Meaning-Centered Psychotherapy.
Study NCT02153619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: questionnaires assessments
Study NCT00629369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extra 3 mouth guard, Shock doctor mouth guard v3.0
Description: Dental mouthguard, molded for each individual patient when in labor. The device is put in the water then in microwave for one minute to soften the device. The device is then applied to the patient's mouth for over 10 seconds to mold it.
Study NCT04133688 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ASC
Description: mobile app
Study NCT04133688 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ASC
Description: mobile app
Study NCT02557880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Application Diary
Description: Tool used to document sleep hygiene.
Study NCT02557880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment As Usual
Description: Sleep hygiene counseling
Study NCT02557880 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment As Usual
Description: Sleep hygiene counseling
Study NCT04300166 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Telemedicine & Humidification
Description: Wireless control of CPAP usage, adherence, leakage and humidifier usage
Study NCT04518579 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thoracic epidural
Description: undergo insertion of an epidural catheter, between T9 and T11 in patients undergoing left-sided resections and between T8 and T10 in patients undergoing right-sided resections
Study NCT00593190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gas SF6 (Sulfur Hexafluoride)
Description: ONCE
Study NCT04635540 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Brochure
Description: Educational brochure on decreased empathy and emotion recognition in patients with neurodegenerative disease
Study NCT02874976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active and Active Phototherapy
Description: Participants performed a aerobic training. Ninety-six subjects practice a regular aerobic exercise program on a treadmill was applied 3 times a week for 12 weeks,each session lasting 30 minutes, ranging between 70-80 % of maximum heart rate intensity and the evaluations are done monthly through a maximum progressive exercise protocol. Phototherapy, active or placebo, were applied in 9 different points of quadriceps,6 points in the posterior thigh and two points in the gastrocnemius muscle, depending the group randomized, before and after each training session.
Study NCT02874976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active and Placebo Phototherapy
Description: Participants performed a aerobic training. Ninety-six subjects practice a regular aerobic exercise program on a treadmill was applied 3 times a week for 12 weeks,each session lasting 30 minutes, ranging between 70-80 % of maximum heart rate intensity and the evaluations are done monthly through a maximum progressive exercise protocol. Phototherapy, active or placebo, were applied in 9 different points of quadriceps,6 points in the posterior thigh and two points in the gastrocnemius muscle, depending the group randomized, before and after each training session.
Study NCT02874976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placebo and active Phototherapy
Description: Participants performed a aerobic training. Ninety-six subjects practice a regular aerobic exercise program on a treadmill was applied 3 times a week for 12 weeks,each session lasting 30 minutes, ranging between 70-80 % of maximum heart rate intensity and the evaluations are done monthly through a maximum progressive exercise protocol. Phototherapy, active or placebo, were applied in 9 different points of quadriceps,6 points in the posterior thigh and two points in the gastrocnemius muscle, depending the group randomized, before and after each training session.
Study NCT02874976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placebo and Placebo Phototherapy
Description: Participants performed a aerobic training. Ninety-six subjects practice a regular aerobic exercise program on a treadmill was applied 3 times a week for 12 weeks,each session lasting 30 minutes, ranging between 70-80 % of maximum heart rate intensity and the evaluations are done monthly through a maximum progressive exercise protocol. Phototherapy, active or placebo, were applied in 9 different points of quadriceps,6 points in the posterior thigh and two points in the gastrocnemius muscle, depending the group randomized, before and after each training session.
Study NCT01038999 — intervention group
Intervention type: BIOLOGICAL
Intervention: Peripheral blood biological tests
Description: A group and B group will be evaluated three times, at baseline, then every 12 months during 3 years. In case of initiation or changing of antiretroviral therapy, patients will be evaluated once more. Control subjects will be only evaluated at baseline.
Study NCT02679118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sentire
Description: The device, at predetermined time points, will draw a small amount of gas from the abdomen. Upon obtaining the samples, the machine will analyze the sample for evidence of bowel gas. After each sample, the device will be purged prior to the acquisition of the next gas sample. The results of the analysis of the gas samples will be recorded for future analysis.
Study NCT02507700 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Popliteal block
Description: In group P, popliteal block will be performed with ultrasound guidence.
Study NCT02507700 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane will be used to all patient's for anesthesia induction and maintenance
Study NCT02507700 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane will be used to all patient's for anesthesia induction and maintenance
Study NCT02507700 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: For recognize the nerve (sciatic nerve), ultrasound will be used in group P.
Study NCT02507700 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Plaster cover
Description: Plaster cover will be used to control group for sham procedure
Study NCT02507700 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine
Description: Bupivacaine 0.25% will be performed for popliteal block to group P.
Study NCT02507700 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Laryngeal mask airway
Description: After anesthesia induction, laryngeal mask airway will be inserted to all patients
Study NCT02507700 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal mask airway
Description: After anesthesia induction, laryngeal mask airway will be inserted to all patients
Study NCT03331640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OFF
Description: OFF:~5-FU 2000 mg/m2 as 24 hour infusion + Na folinic acid 200 mg/m2 on D1, 8, 15, 22 Oxaliplatin 85 mg/m2 on D8, 22 3 weeks rest after D22; Cycle q42d
Study NCT03331640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI Protocol
Description: Irinotecan 180 mg /m2 5-FU 400 mg/m2 (bolus) + 2400 mg/m2 as 46 hour infusion Na folinic acid 200 mg/m2 Cycle q2w
Study NCT01999517 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Nitroglycerin
Study NCT01999517 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Fluids
Study NCT01999517 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV Fluids
Study NCT01926496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ingenol Mebutate Gel, 0.015%
Description: Ingenol mebutate gel 0.015 % (Picato®) applied on the selected treatment area. Retreatment if the treatment field is not completely cleared of AKs.
Study NCT01926496 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Imiquimod Cream, 5%
Description: Imiquimod 5% cream applied to the selected treatment area. Retreatment if the treatment field is not completely cleared of AKs
Study NCT03133416 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PRP preparation
Study NCT03133416 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Study NCT03133416 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PRP and physiotherapy
Study NCT01738646 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vorinostat
Study NCT01738646 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Study NCT02209532 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PINPOINT
Description: PINPOINT® Near Infrared Fluorescence Imaging to identify lymph nodes
Study NCT04241055 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Values affirmation exercise
Description: In the experimental values affirmation condition, participants spend 10-15 minutes completing a guided reflection regarding values that are personally important (see Logel and Cohen, 2012; Brady, Griffiths, \& Cohen, in prep).
Study NCT04241055 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active control exercise
Description: In the active control condition, participants spend 10-15 minutes completing a guided reflection regarding values that are not personally important but could be important to someone else (see Logel and Cohen, 2012; Brady, Griffiths, \& Cohen, in prep).
Study NCT04390204 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervenions
Description: * Motor control exercises~* A supervised home self-rehabilitation program
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 1
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed a dish made with thick pasta, minced meat and béchamel sauce and 20 g kalamata olives. The meal provided 794 kcal and contained approximately 500 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 2
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed grilled chicken with vegetables.The meal provided 399 kcal and contained approximately 300 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 3
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed baked giant beans and 20g kalamata olives. The meal provided 502 kcal and contained approximately 300 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 4
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed a dish made with thick pasta, minced meat and béchamel sauce and 20 g kalamata olives and 11 ml extra virgin olive oil. The meal provided 893 kcal and contained approximately 600 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 5
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed grilled chicken with vegetables and 11 ml extra virgin olive oil. The meal provided 497 kcal and contained approximately 300 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT02928016 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mixed meal 6
Description: 20 adults with type 1 diabetes (T1DM) on intensive insulin treatment consumed baked giant beans and 20 g kalamata olives and 11 ml extra virgin olive oil. The meal provided 601 kcal and contained approximately 400 kcal from protein and fat. Insulin requirements for the test meal were calculated based on the carbohydrate content of the dish according to the personalised carbohydrate to insulin ratio.
Study NCT01166880 — intervention group
Intervention type: DEVICE
Intervention: Laser Speckle Imaging
Description: Laser Speckle Imaging Infant Head Blood flow
Study NCT00974480 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Redermic
Description: Cosmetic cream formulation 609637 43.
Study NCT00974480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Redermic
Description: Cosmetic cream formulation 609637 43.
Study NCT00202878 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for ezetimibe 10 mg/simvastatin 40 mg combination
Description: one tablet orally daily.
Study NCT02250703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: oral midazolam 0.5mg/kg upto maximum dose of 15mg
Study NCT02250703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: intranasal dexmedetomidine 2mcg/kg upto maximum dose of 100mcg
Study NCT03008200 — intervention group
Intervention type: DEVICE
Intervention: ultrasound examination
Description: intrauterine fetal pulmonary artery acceleration time to ejection time ratio measurement via ultrasound
Study NCT01474018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QR-bromocriptine
Description: The study drug is added-on to patients on existing type 2 diabetes treatment with insulin +metformin+exercise/nutritional counseling. The study drug is titrated up starting at one 0.8mg tab daily for 1 week, then 2 (0.8mg) tablets for week 2, then 3 tablets for week 3, then 4 tablets for week 4, then 5 tablets for week 5, then six tablets for week 6 (total 4.8). The limiting factor is nausea at which point the patients will back down the highest tolerated dose and continue on that dose for the remainder of the 6 months of the study.
Study NCT02030236 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooling
Description: Temperature reached Duration of exposure to cold.
Study NCT04229537 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCT-I10A
Description: 200 mg intravenous (IV) on Day 1 of Q3W.
Study NCT04229537 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCT200
Description: 6mg/kg intravenous (IV) on Day 1 of QW, then 8mg/kg intravenous (IV) on Day 1 of Q2W
Study NCT04229537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Capecitabine and Oxaliplatin.
Study NCT04506099 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TINS Active protocol
Description: Electrical stimulation will be applied to the T6-T11 levels of intercostal nerves, as close to the level directly below the level of injury as possible. Electrodes 2 inch by 4 inch will be placed according to anatomic landmarks with the negative electrode applied to the lateral ribcage and the positive electrode applied to the ventral aspect, verified with contraction of the rectus abdominis. The intensity level will be set to the amperage immediately under the threshold for motor contraction. If there is no contraction seen, patients will be excluded. In addition, if the patient perceives pain, the intensity will be lowered until comfortable. Stimulation frequency of 20 Hz and pulse width of 200ms in continuous mode will be used.
Study NCT04506099 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham protocol
Description: Electrical stimulation will be applied to the T6-T11 levels of intercostal nerves, as close to the level directly below the level of injury as possible until contraction is seen in the rectus abdominis. Stimulation frequency of 20 Hz and pulse width of 200ms in continuous mode will be used. Electrodes 2 inch by 4 inch will be placed according to anatomic landmarks with the negative electrode applied to the lateral ribcage and the positive electrode applied to the ventral aspect. The intensity level will be set to 1mA . If there is no contraction seen, patients will be excluded. In addition, if the patient perceives pain, the intensity will be lowered until comfortable.
Study NCT01636518 — intervention group
Intervention type: PROCEDURE
Intervention: Standard of Care
Description: Standard of care procedure as determined by treating physician for Atrial Fibrillation
Study NCT02606149 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Truthful information on chemotherapy risks
Description: One of two trained oncologist will meet the patient and inform him following an interview-guideline
Study NCT02606149 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of information
Study NCT01613898 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood tests
Description: Blood tests
Study NCT03161444 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biological sample collection
Description: A blood sample collection for the study will be taken to each participant Each subject enrolled must have previously participated to the study CHIKVIH.
Study NCT00126490 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Given subcutaneously
Study NCT00126490 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study NCT00126490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01671878 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Reference Glucose
Study NCT01671878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test Food 1 (Cereal)
Study NCT01671878 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test Food 2 (Biscuit)
Study NCT02813577 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Lutonix® 035 Drug Coated Balloon PTA Catheter
Description: Female subjects will receive the Lutonix® 035 Drug Coated Balloon PTA Catheter.
Study NCT04468152 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary habits and intake
Description: Optical coherence tomography (OCT) withdrawals and central foveal thickness (CFT) evaluations of those included in the study were made by the doctor and directed to the dietician (researcher). The dietary intake of participants was assessed using a validated quantitative food frequency questionnaire (QFFQ) (21). The total food intake was then converted to total nutrient intake based on the food's nutrient profile. Standardized food recipes for Turkey and the Nutrition Information System (BEBIS) program, which is a food composition database for nutrient estimation, were used to determine the average daily energy and nutrient intake for each participant.
Study NCT03727308 — intervention group
Intervention type: BEHAVIORAL
Intervention: Medical abortion pills sourced from pharmacies
Description: One cohort using medical abortion pills sourced from pharmacies